iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
Global Hepatitis Summit - Retreatment With Sofosbuvir/Velpatasvir/Voxilaprevir for 12 Weeks Is Safe and Effective for Patients Who Have Previously Received Sofosbuvir/Velpatasvir or Sofosbuvir/Velpatasvir/Voxilaprevir
 
  Reported by Jules Levin

0618181

Peter Ruane,1 Simone I. Strasser,2 Edward J. Gane,3 Robert H. Hyland,4 Jiang Shao,4 Hadas Dvory-Sobol,4 Tram Tran,4 Luisa M. Stamm,4 Diana M. Brainard,4 Lisa Nyberg,5 Stephen Shafran6 1Ruane Medical & Liver Health Institute, Los Angeles, California, USA; 2AW Morrow Gastroenterology and Liver Centre, Sydney, New South Wales, Australia; 3The University of Auckland, New Zealand; 4Gilead Sciences, Inc., Foster City, California; 5Kaiser Permanente, San Diego, California; 6University of Alberta, Edmonton, Canada

0618182

0618183

0618184

0618185

0618186

0618187

0618188

0618189

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org